验证数据展示
经过测试的应用
Positive IF-P detected in | human tonsillitis tissue |
Positive IF/ICC detected in | Daudi cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL488-67051 targets IL-4RA/CD124 in IF/ICC, IF-P applications and shows reactivity with human samples.
经测试应用 | IF/ICC, IF-P Application Description |
经测试反应性 | human |
免疫原 | IL-4RA/CD124 fusion protein Ag28411 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | interleukin 4 receptor |
别名 | IL4R, 1E4C11, CD124, IL 4 binding protein, IL 4 receptor subunit alpha |
计算分子量 | 90 kDa |
观测分子量 | 120 kDa |
GenBank蛋白编号 | NM_000418 |
基因名称 | IL-4R |
Gene ID (NCBI) | 3566 |
RRID | AB_2919413 |
偶联类型 | CoraLite® Plus 488 Fluorescent Dye |
最大激发/发射波长 | 493 nm / 522 nm |
形式 | Liquid |
纯化方式 | Protein G purification |
UNIPROT ID | P24394 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
IL-4 receptor alpha chain (IL-4RA), also known as CD124, is a transmembrane glycoprotein expressed on a wide variety of hematopoietic and non-hematopoietic cells. It is a receptor for both IL-4 and IL-13. IL-4RA can complex with the common gamma chain (IL-2R gamma or CD132) and utilizes JAK1 and JAK2 for signal transduction, while complexes of IL-4RA with IL-13RA1 subunit mediate signals via JAK2 and Tyk2. The IL-4 response is involved in promoting Th2 differentiation. The IL-4/IL-13 responses are involved in regulating IgE production and, chemokine and mucus production at sites of allergic inflammation.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 IL-4RA/CD124 antibody CL488-67051 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |